Insider Shareholders with Direct Ownership of Pandion Therapeutics, Inc. (PAND)
This section provides a comprehensive overview of the insiders with direct ownership of Pandion Therapeutics, Inc. (PAND). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Pandion Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Boxer Capital, Llc
> 10% Shareholder |
2,107,513 | 0 | 2,107,513 $126 Million | 1 |
Jul 21, 2020
Added 25.52%
|
|
Daniel J. Becker
Director |
0 | 1,000 | 0 $0 | 1 |
Apr 01, 2021
Reduced 100.0%
|
|
Vikas Goyal
Officer |
0 | 87,764 | 0 $0 | 1 |
Apr 01, 2021
Reduced 100.0%
|
|
Rahul Kakkar
Chief Executive Officer |
0 | 14,000 | 0 $0 | 1 |
Apr 01, 2021
Reduced 100.0%
|
|
Edward D. Freedman
Chief Operating Officer |
0 | 54,460 | 0 $0 | 1 |
Apr 01, 2021
Reduced 100.0%
|
|
Joanne L. Viney
Officer |
0 | 503,254 | 0 $0 | 1 |
Apr 01, 2021
Reduced 100.0%
|
|
Eric D Larson
Vice President, Finance |
0 | 22,125 | 0 $0 | 1 |
Apr 01, 2021
Reduced 100.0%
|
|
John Sundy
Chief Medical Officer |
0 | 115,826 | 0 $0 | 1 |
Apr 01, 2021
Reduced 100.0%
|
|
Alan L Crane
Director |
0 | 84,158 | 0 $0 | 1 |
Apr 01, 2021
Reduced 100.0%
|
|
Nancy Stagliano
Director |
0 | 1,000 | 0 $0 | 1 |
Apr 01, 2021
Reduced 100.0%
|
|
Donald Frail
Director |
0 | 61,113 | 0 $0 | 1 |
Apr 01, 2021
Reduced 100.0%
|